CK

Carly Kenselaar

#61 out of 1699 analysts
Citigroup
Automatically Tracked
Tracking: 0 Updated: Jun 15 at 01:55 PM

Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.

Gain and growth charts are calculated per selected timeframe:
105.85%
Gain +2.73%
Monthly
3.16%
Yearly
45.24%
Drawdown
39.63%
$205,846.12
Equity
Holdings
$0
Cash
$205,846.12
Investment
$0
$105,846.12
Profit +$5,467.14
Realized
$105,846.12
Unrealized
$0
Dividends
$0
$205,846.12
Cash
Deposits
$100,000
Withdrawals
$0
Commissions
$0

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
2.73%
Profit
$5,467.14
Win %
100%
This Week
Compared To Last Week
Gain
5.88%
Profit
$11,431.29
Win %
100%
This Month
Compared to last month
Gain
42%
Profit
$60,884.06
Win %
100%
This Year
Compared to last year
Gain
32.84%
Profit
$50,884.3
Win %
66%
Travere Therapeutics Inc. logo
TVTX Travere Therapeutics Inc.
+$100,974.67
Krystal Biotech Inc. logo
KRYS Krystal Biotech Inc.
+$4,871.45
No Data
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
7
Longs Won
4/7 57%
Profit Factor
2.81
Profitability
Shorts Won
0/0 0%
Standard Deviation
$46,598.5
Average Win
$41,108.54
Best Trade
(Sep 19) $85,569.03
Sharpe Ratio
-7.92
Average Loss
-$19,529.34
Worst Trade
(Jun 04) -$47,494.44
Z-Score
2.61 (99.09%)
Commissions
$0
Avg. Trade Length
2m 4w 1d
Expectancy
$15,120.87
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss <0.01% 0.3% 1.71% 4.76% 9.86% 17.33% 27.48% 40.58% 56.88% 76.61%
Consecutive Losing Trades 11 9 8 7 6 5 4 3 2 1
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV